PDK2 and leukemia: In contrast to the metabolic characteristic of leukemia stem cells described here, normal hematopoietic stem cells were recently shown to display glycolytic advantage including high expression of phosphofructokinase, pyruvate dehydrogenase kinase 2 and 4 [3].